ATARA Biotherapeutics (ATRA) Granted FDA Clearance to Proceed with Enrollment at U.S. Sites for Ongoing Global Phase 1 Clinical Study to Evaluate ATA188
Tweet Send to a Friend
Atara Biotherapeutics, Inc. (NASDAQ: ATRA) today announced that it received clearance of its Investigational New Drug (IND) application from the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
